Clinical Trials in Phoenix

Showing 1401-1420 of 16,646 trials

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

NCT02985684

Evaluate the safety and efficacy of the GORE® CARDIOFORM ASD Occluder in the percutaneous closure of ostium secundum atrial septal defects (ASDs)

Atrial Septal Defect

W.L.Gore & Associates125 participantsStarted Mar 2017

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +19 more locations

RECRUITINGPhase 4< 1 mile

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

NCT05201781

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Multiple Myeloma

Janssen Research & Development, LLC295 participantsStarted Mar 2022

Phoenix, Arizona, United States • Duarte, California, United States • San Francisco, California, United States +47 more locations

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Find Trials by Condition in Phoenix

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Light Exposure, Migraine Outcomes, and Sleep Quality

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Mucopolysaccharidosis VII Disease Monitoring Program

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Actinium Therapy for Late-stage Aggressive Sarcomas

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Donidalorsen Treatment in Children With Hereditary Angioedema

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma